About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 200 record(s)
Req # A-2020-001187
Adverse Reaction Reports (AERs). Report numbers: E2B_02453239, E2B_02453459, E2B_02453467, E2B_02453823, E2B_02454148, E2B_02454167, E2B_02454183, E2B_02454191, E2B_02454197, E2B_02454216, E2B_02454631, E2B_02454633, E2B_02454635, E2B_02454669, E2B_02454723, E2B_02454761, E2B_02454976, E2B_02455619, E2B_02455654, E2B_02456369.Organization: Health Canada
September 2021
Req # A-2020-001214
Adverse Reaction Reports (AERs). Report numbers: E2B_02493081, E2B_02493670, E2B_02493847, E2B_02493905, E2B_02494042, E2B_02494050, E2B_02494149, E2B_02494778, E2B_02495205, E2B_02495562, E2B_02496605, E2B_02496852, E2B_02496943, E2B_02497035, E2B_02497883, E2B_02497950, E2B_02498042, E2B_02498144, E2B_02498848, E2B_02499081.Organization: Health Canada
September 2021
Req # A-2020-001219
For Health Canada's Request for Proposal (RFP) 1000224008 - Access to Information and Privacy Consultant - Intermediate Level Consultants, copies of winning vendor proposals (as originally submitted) for each vendor.Organization: Health Canada
September 2021
Req # A-2020-001222
Adverse Reaction Reports (AERs). Report numbers: E2B_02516214, E2B_02517163, E2B_02517945, E2B_02518015, E2B_02518368, E2B_02518370, E2B_02518384, E2B_02518591, E2B_02519461, E2B_02520074, E2B_02520395, E2B_02521130, E2B_02521419, E2B_02521617, E2B_02521624, E2B_02521656, E2B_02521667, E2B_02521669, E2B_02521700, E2B_2521715.Organization: Health Canada
September 2021
Req # A-2020-001285
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123099-77.Organization: Health Canada
September 2021
Req # A-2020-001348
Adverse Reaction Reports (AERs). Report numbers: E2B_02787623, E2B_02789898, E2B_02790011, E2B_02790188, E2B_02790670, E2B_02791910, E2B_02791948, E2B_02792258, E2B_02793925, E2B_02794600, E2B_02794759, E2B_02794764, E2B_02795515, E2B_02796216, E2B_02797672, E2B_02797844, E2B_02799044, E2B_02799045, E2B_02799200, E2B_02799814.Organization: Health Canada
September 2021
Req # A-2020-001384
Adverse Drug Reactions (ADRs): Report numbers: E2B_02871133, E2B_02871154, E2B_02871233, E2B_02871285, E2B_02871615, E2B_02871716, E2B_02871897, E2B_02871900, E2B_02871911, E2B_02872064, E2B_02872147, E2B_02872598, E2B_02872619, E2B_02872789, E2B_02873009, E2B_02873022, E2B_02873236, E2B_02873321, E2B_02873551, E2B_02873831.Organization: Health Canada
September 2021
Req # A-2020-001388
Adverse Reaction Reports (AERs). Report numbers: E2B_02874158, E2B_02874254, E2B_02874537, E2B_02874790, E2B_02874971, E2B_02875389, E2B_02875802, E2B_02877193, E2B_02877242, E2B_02877502, E2B_02878258, E2B_02878282, E2B_02881001, E2B_02881011, E2B_02881363, E2B_02881798, E2B_02881989, E2B_02882691, E2B_02882694, E2B_02884868.Organization: Health Canada
September 2021
Req # A-2020-001445
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03045161, E2B_03076327, E2B_03046764, E2B_03076749, E2B_03095299, E2B_03138761, E2B_03139156, E2B_03141109, E2B_03141401, E2B_03070692, E2B_03010220, E2B_03138579, E2B_03053162, E2B_03011992.Organization: Health Canada
September 2021
Req # A-2020-001468
All records which indicate the efficacy (pros/cons) of wearing masks (face coverings) by the general public is an effective method of stopping the spread of infectious disease, such as influenza or COVID-19. Any safety risks associated with the long-term wearing of masks or face-coverings by asymptomatic or healthy people.Organization: Health Canada
September 2021